The René Huguenin Hospital is a renowned teaching hospital in Saint-Cloud. Part of the Curie Institute and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University. Established in 2010, it was named in honour of René Huguenin, Professor of Pathology and Director of the Institut Gustave Roussy.

There are 146 beds in Centre René Huguenin.

During the past decade, Centre René Huguenin conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 17 clinical trials were completed, i.e. on average, 42.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre René Huguenin" #1 sponsor was "UNICANCER" with 38 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials sponsored, "Institut Curie" with 12 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored and "The Lymphoma Academic Research Organisation" with 8 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre René Huguenin" #1 collaborator was "Hoffmann-La Roche" with 5 trials as a collaborator, "UNICANCER" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator and "National Cancer Institute, France" with 3 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "Centre René Huguenin" are "Breast Cancer" (37 trials), "Colorectal Cancer" (9 trials), "Ovarian Cancer" (7 trials), "Prostate Cancer" (5 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "Centre René Huguenin" in a lesser frequency.

Most popular intervention types in "Centre René Huguenin" are "Drug" (108 trials), "Procedure" (26 trials), "Radiation" (19 trials), "Other" (17 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (20 trials), "radiation therapy" (12 trials), "cisplatin" (9 trials), "docetaxel" (9 trials) and "leucovorin calcium" (8 trials). Other intervention names were less common.

The vast majority of trials in "Centre René Huguenin" are 90 trials for "All" genders, 45 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Centre René Huguenin". undefined are not yet recruiting, 11 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Centre René Huguenin, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Centre René Huguenin, 8 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".